Your browser doesn't support javascript.
loading
Increased sMICA and TGFß1 levels in HNSCC patients impair NKG2D-dependent functionality of activated NK cells.
Klöß, Stephan; Chambron, Nicole; Gardlowski, Tanja; Arseniev, Lubomir; Koch, Joachim; Esser, Ruth; Glienke, Wolfgang; Seitz, Oliver; Köhl, Ulrike.
Afiliação
  • Klöß S; Institute for Cellular therapeutics; IFB-Tx; Hannover Medical School ; Hannover, Germany.
  • Chambron N; Department of Oral; Cranio-Maxillofacial and Facial Plastic Surgery; Klinikum Hanau GmbH ; Hanau, Germany.
  • Gardlowski T; Institute for Cellular therapeutics; IFB-Tx; Hannover Medical School ; Hannover, Germany.
  • Arseniev L; Institute for Cellular therapeutics; IFB-Tx; Hannover Medical School ; Hannover, Germany.
  • Koch J; Georg-Speyer-Haus; Institute for Tumor Biology and Experimental Therapy ; Frankfurt, Germany.
  • Esser R; Institute for Cellular therapeutics; IFB-Tx; Hannover Medical School ; Hannover, Germany.
  • Glienke W; Institute for Cellular therapeutics; IFB-Tx; Hannover Medical School ; Hannover, Germany.
  • Seitz O; Department of Oral; Cranio-Maxillofacial and Facial Plastic Surgery; Klinikum Hanau GmbH ; Hanau, Germany.
  • Köhl U; Institute for Cellular therapeutics; IFB-Tx; Hannover Medical School ; Hannover, Germany.
Oncoimmunology ; 4(11): e1055993, 2015 Nov.
Article em En | MEDLINE | ID: mdl-26451327
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Alemanha